These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 29691646)

  • 1. Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer.
    Papadia A; Gasparri ML; Radan AP; Stämpfli CAL; Rau TT; Mueller MD
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1385-1393. PubMed ID: 29691646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer.
    Papadia A; Imboden S; Siegenthaler F; Gasparri ML; Mohr S; Lanz S; Mueller MD
    Ann Surg Oncol; 2016 Jul; 23(7):2206-11. PubMed ID: 26790667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of sentinel lymph node mapping for endometrial cancer.
    Togami S; Kawamura T; Fukuda M; Yanazume S; Kamio M; Kobayashi H
    Int J Gynaecol Obstet; 2018 Dec; 143(3):313-318. PubMed ID: 30125949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes?
    Ye L; Li S; Lu W; He Q; Li Y; Li B; Wang X; Yan Q; Wan X
    Oncologist; 2019 Dec; 24(12):e1381-e1387. PubMed ID: 31270269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.
    Hagen B; Valla M; Aune G; Ravlo M; Abusland AB; Araya E; Sundset M; Tingulstad S
    Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?
    Papadia A; Gasparri ML; Siegenthaler F; Imboden S; Mohr S; Mueller MD
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):491-497. PubMed ID: 27834005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
    Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
    Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
    Kim JH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    World J Surg Oncol; 2018 Mar; 16(1):52. PubMed ID: 29523141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer.
    Body N; Grégoire J; Renaud MC; Sebastianelli A; Grondin K; Plante M
    Gynecol Oncol; 2018 Aug; 150(2):267-273. PubMed ID: 29909967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study - a multicentric analysis of predictors of failed mapping.
    Sozzi G; Fanfani F; Berretta R; Capozzi VA; Uccella S; Buono N; Giallombardo V; Di Donna MC; Monterossi G; Restaino S; Capasso I; Dinoi G; Scambia G; Chiantera V
    Int J Gynecol Cancer; 2020 Nov; 30(11):1713-1718. PubMed ID: 32868384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
    Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic near-infrared fluorescent imaging as an alternative option for sentinel lymph node mapping in endometrial cancer: A prospective study.
    Taşkın S; Şükür YE; Altın D; Ersöz CC; Turgay B; Kankaya D; Güngör M; Ortaç F
    Int J Surg; 2017 Nov; 47():13-17. PubMed ID: 28919095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer.
    Kim YN; Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Int J Gynecol Cancer; 2020 Mar; 30(3):318-324. PubMed ID: 31992601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic sentinel lymph node biopsy in endometrial cancer-a simplified algorithm based on histology and lymphatic anatomy.
    Bollino M; Geppert B; Lönnerfors C; Falconer H; Salehi S; Persson J
    Int J Gynecol Cancer; 2020 Mar; 30(3):339-345. PubMed ID: 32075897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.
    Baiocchi G; Mantoan H; Kumagai LY; Gonçalves BT; Badiglian-Filho L; de Oliveira Menezes AN; Faloppa CC; De Brot L; da Costa AABA
    Ann Surg Oncol; 2017 Dec; 24(13):3981-3987. PubMed ID: 29058141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
    Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
    Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer.
    Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Plante M
    Gynecol Oncol; 2017 Dec; 147(3):549-553. PubMed ID: 28942993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.
    Soliman PT; Westin SN; Dioun S; Sun CC; Euscher E; Munsell MF; Fleming ND; Levenback C; Frumovitz M; Ramirez PT; Lu KH
    Gynecol Oncol; 2017 Aug; 146(2):234-239. PubMed ID: 28528918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of sentinel node biopsy in non-endometrioid, high-grade and/or deep myoinvasive endometrial cancer: A Turkish gynecologic oncology group study (TRSGO-SLN-006).
    Altın D; Taşkın S; Ortaç F; Tokgözoğlu N; Vatansever D; Güler AH; Güngör M; Taşçı T; Beşe T; Turan H; Kahramanoğlu İ; Yalçın İ; Çelik Ç; Demirkıran F; Köse F; Arvas M; Ayhan A; Taşkıran Ç
    Gynecol Oncol; 2022 Mar; 164(3):492-497. PubMed ID: 35033380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.